Learning Objectives:

1. What is levosimendan, mechanism of action?


2. Overview of the literature on levosimendan for patients with heart failure.


  3. What are the remaining indications for levosimendan after 23 years of clinical investigation?

Session date: 
10/06/2023 - 12:00pm to 1:00pm CDT
In-Person / Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Bernard Cholley, MD, PhD